|
Hans Biomed Corporation - Company Profile Snapshot
| Company Profile: |
Hans Biomed Corporation |
| Ticker: |
042520 |
| Exchanges: |
SEO |
| 2008 Sales: |
12,305,000,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
KOREA (SOUTH) |
| Employees: |
|
Business Description
Hans Biomed Corporation. The Company's principal activity is providing biotechnology products. It provides three categories of products: products for skin implant, products for bone implant and silicone products. The products for skin implant include SureDerm, which is acellular human dermis used for the repair or replacement of damaged soft tissue; GPS, which is glycerol preserved skin used as wound dressing, and Sheba, which is micronized injectable human tissue for the correction of wrinkles and dents on the face. The products for bone implant include SureFuse, which is mixture of demineralized bone matrix (DBM) used for forming normal healthy bone by stimulation of mesenchymal cell proliferation; ExFuse, which is DBM to which cancellous bone chip is added, and SureOss, which is made of freeze dried cortical bone and helps bone regeneration. The silicone products include treatments for scars, and silicone materials for facial implant, nasal implant, breast implant and others.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
